Scope Biosciences is a startup developing CRISPR-Cas based molecular diagnostics. Here are details of Scope Biosciences’ latest funding round :
🚀 Launch
/
🏭 Industry
Biotechnology
🧠Management
Niek Savelkoul (CEO), Jurre Steens (CTO)
💸 Funding & Investors
| INVESTMENT (October 2023) | €500,000 |
| INVESTORS (October 2023) | led by SHIFT Invest’s Thematic Technology Transfer fund and OostNL. |
🎯 Funding purpose
Develop, launch, and commercialise agricultural tests using the innovative scopeDx molecular diagnostic platform.
🌐 Country HQ
The Netherlands (Wageningen)